Ironwood Pharmaceuticals | IRWD - 现金及等价物



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.31
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 666.8M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 113.04M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


现金及等价物 更改 日
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Akebia Therapeutics USD 155.55M 7.1M 2026-06
Almirall EUR 337.77M 14.83M 2025-12
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amarin USD 143.56M 12.5M 2026-06
Ardelyx USD 31.21M 36.79M 2026-03
Astellas Pharma JPY 281.6B 93.23B 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
Charles River Laboratories USD 192.02M 195K 2026-06
Coherus Biosciences USD 82.92M 32.32M 2026-06
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Incyte USD 3.98B 33.45M 2026-06
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
MacroGenics USD 66.52M 9.3M 2026-03
Moderna USD 1.72B 185M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Pacira USD 205.88M 61.57M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Puma Biotechnology USD 53.52M 1.14M 2025-09
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Takeda JPY 460.98B 134.07B 2026-06
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12